Bode John B

Track

Insider profile

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return -0% 8.2% 15.1%
Success rate 38% 68% 82%
Transactions
10 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Bode John B's trades of Zevra Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-08 2026-07-08
PrS Proposed sale
67,420
326.16
US$1,595,293 		67,420 326.16 US$1,595,293
2025-08-20 2025-08-19
B Purchase
87,545 +36.0%
305.19
US$4,875,139 		87,545 +36.0% 305.19 US$4,875,139
2025-03-21 2025-03-19
B Purchase
91,921 -7.3%
175.70
US$2,355,254 		91,921 -7.3% 175.70 US$2,355,254
2024-07-15 2024-07-12
B Purchase
10,000 +50.0%
5.87
US$58,661 		10,000 +50.0% 5.87 US$58,661
2023-09-06 2023-09-05
B Purchase
10,000 +100.0%
5.13
US$51,333 		10,000 +100.0% 5.13 US$51,333
2023-05-19 2023-05-18
B Purchase
2,451 +32.5%
5.05
US$12,378 		2,451 +32.5% 5.05 US$12,378
2023-05-19 2023-05-18
B Purchase
100 +1.3%
5.05
US$504 		100 +1.3% 5.05 US$504
2023-05-19 2023-05-18
B Purchase
4,759 +176.9%
5.04
US$23,985 		4,759 +176.9% 5.04 US$23,985
2023-05-19 2023-05-18
B Purchase
1,000 +59.2%
5.04
US$5,040 		1,000 +59.2% 5.04 US$5,040
2023-05-19 2023-05-18
B Purchase
300 +21.6%
5.04
US$1,512 		300 +21.6% 5.04 US$1,512
2023-05-19 2023-05-18
B Purchase
1,390 +inf%
5.04
US$6,999 		1,390 +inf% 5.04 US$6,999